Karys M. Hildebrand, PhD (she/her/hers)

MD/PhD Candidate
University of Calgary, Canada

I am currently a second year medical student at the University of Calgary. I completed my PhD in 2024 investigating STING as an immunotherapy for soft tissue sarcoma. Since this time I continue to work on this project and have expanded into other clinical and preclinical projects. I am interested in pursuing a career in orthopaedic oncology.

Poster(s):

• (P 238) INVESTIGATING HOW MACROPHAGES INFILTRATE THE TUMOUR MICROENVIRONMENT AND INFLUENCE THE EFFICACY OF CAR T THERAPY IN A MURINE MODEL OF STS

• (P 239) CHARACTERIZING THE ROLES OF T-CELLS IN THE CONTEXT OF TUMOR CLEARANCE AND MEMORY IN THE KP MODEL OF SARCOMA FOLLOWING STING THERAPY

• (P 378) HIGH DOSE RADIATION THERAPY PROMOTES IMMUNE SUPPRESSIVE MACROPHAGE PHENOTYPES, WHEREAS LOW DOSE RADIATION THERAPY PROMOTES IMMUNOGENIC MACROPHAGE PHENOTYPES IN A MURINE MODEL OF SOFT TISSUE SARCOMA